Suppr超能文献

粘杆菌素,来自黄色粘球菌(粘杆菌目)的新型抗生素。I. 生产、理化性质、生物学特性及作用机制。

The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action.

作者信息

Gerth K, Jansen R, Reifenstahl G, Höfle G, Irschik H, Kunze B, Reichenbach H, Thierbach G

出版信息

J Antibiot (Tokyo). 1983 Sep;36(9):1150-6. doi: 10.7164/antibiotics.36.1150.

Abstract

From the cell mass and culture supernatant of Myxococcus xanthus strain Mx X12 an antibiotic activity against yeasts, molds and some Gram-positive bacteria could be extracted. It consisted of 4 biologically active compounds which were named myxalamid A, B, C and D. The main component, myxalamid B, was shown to block in beef heart submitochondrial particles the respiratory chain at the site of complex I, i.e. NADH: ubiquinone oxidoreductase. The myxalamids are new antibiotics.

摘要

从黄色粘球菌Mx X12菌株的细胞团和培养上清液中,可以提取出一种对酵母、霉菌和一些革兰氏阳性菌具有抗菌活性的物质。它由4种生物活性化合物组成,分别命名为粘霉素A、B、C和D。主要成分粘霉素B在牛肉心亚线粒体颗粒中,可阻断呼吸链复合体I处,即NADH:泛醌氧化还原酶的作用。粘霉素是新型抗生素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验